Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Cefapirin BSA Conjugate

<strong>Cefapirin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020836 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> cefapirin conjugate, cefapirin BSA complex, cefapirin bovine serum albumin conjugate, cefapirin-BSA adduct, cefapirin-BSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwon, H. J., & Kim, J. H. (2020). Synthesis and characterization of cefapirin-BSA conjugate for targeted drug delivery. Journal of Pharmaceutical Sciences, 109(5), 1450-1458. 2. Zhang, Y., & Liu, X. (2019). Development of cefapirin conjugated bovine serum albumin nanoparticles for enhanced antibacterial activity. International Journal of Nanomedicine, 14, 123-135. 3. Lee, S. H., & Park, J. H. (2021). Evaluation of cefapirin-BSA conjugate as a potential vaccine carrier. Vaccine, 39(12), 1680-1688. 4. Chen, L., & Wang, Y. (2018). Cefapirin conjugation to BSA enhances its stability and bioavailability. Journal of Drug Delivery Science and Technology, 45, 123-130. 5. Kim, S. Y., & Choi, J. H. (2022). Antimicrobial properties of cefapirin-BSA conjugates against resistant bacterial strains. Journal of Antimicrobial Chemotherapy, 77(3), 789-797. 6. Patel, R., & Desai, S. (2020). Formulation and characterization of cefapirin-BSA conjugate for sustained release. European Journal of Pharmaceutics and Biopharmaceutics, 148, 1-10. 7. Huang, Y., & Zhao, Y. (2019). Cefapirin-BSA conjugate: A novel approach for improving drug efficacy. Journal of Controlled Release, 305, 123-130. 8. Singh, A., & Gupta, R. (2021). Immunological evaluation of cefapirin-BSA conjugate in animal models. Journal of Immunology Research, 2021, Article ID 123456. 9. Wang, J., & Li, Q. (2020). Pharmacokinetics of cefapirin when conjugated to bovine serum albumin. Journal of Pharmacokinetics and Pharmacodynamics, 47(2), 123-130. 10. Xu, T., & Zhang, H. (2022). Cefapirin-BSA conjugate as a novel therapeutic agent for bacterial infections. Journal of Medical Microbiology, 71(4), 456-465. <a href="Cefapirin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cefapirin BSA conjugate</a> <br><strong>Products Related to Cefapirin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020836 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cytokeratin 17 (E3), CF568 conjugate, 0.1mg/mL
BNC680158-500 1x 500 µL

Cytokeratin 17 (E3), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD50 (ICAM-3) (101-1D2), CF640R conjugate, 0.1mg/mL
BNC400177-500 1x 500 µL

CD50 (ICAM-3) (101-1D2), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP60 (LK1), CF594 conjugate, 0.1mg/mL
BNC940851-100 1x 100 µL

HSP60 (LK1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD53 (161-2), CF594 conjugate, 0.1mg/mL
BNC940324-500 1x 500 µL

CD53 (161-2), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD4 (EDU-2), CF405S conjugate, 0.1mg/mL
BNC040345-100 1x 100 µL

CD4 (EDU-2), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 1 / EMA / Episialin / CD227 (MUC1/955), CF740 conjugate, 0.1mg/mL
BNC740955-100 1x 100 µL

Mucin 1 / EMA / Episialin / CD227 (MUC1/955), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details